Acadia Healthcare Company IncImpact on assets 4
Health Care▲ · 2 stocks
Acadia Healthcare Company IncACHC
Mentioned
Tenet Healthcare CorporationTHC
Mentioned
Aging Population▲ · 2 stocks
The Ensign Group IncENSG
Mentioned
UnitedHealth Group IncorporatedUNH
Mentioned
Theme Impact 1
Off-coverage companies
Related news
▲5
Muang Thai Life launches Muang Thai Flexi Retire Series, a highly flexible annuity product
Muang Thai Life Assurance Public Company Limited, or MTL, has launched a new annuity product under the name Muang Thai Flexi Retire Series, and is moving ahead with the full rollout of its Longevity Ecosystem. Chief Executive Officer Sara Lamsam said the company aims to expand its role from providing life and health protection to creating balance across three dimensions: Lifespan, Healthspan and Wealthspan. The new product lets customers choose to pay premiums in a single payment, over five years, or until age 55, 60 or 65; choose to begin receiving annuity income at age 55, 60, 65 or 70; and adjust their retirement plan later without paying additional premiums or undergoing new underwriting. Annuity income can be received annually or monthly, with an option for a first installment of 30% as a lump sum, and policyholders can use the tax deduction for up to 200,000 baht. The product also guarantees no health check. The series comprises Flexi Retire Pro 90/1, Flexi Retire Next 90/1, Flexi Retire 90/5, and Flexi Retire 9055, 9060 and 9065, with sales starting on 1 October 2026. On building the long-term ecosystem, the company has joined forces with 44 senior living and nursing home partners for elderly care and recuperating patients, covering the whole country. Annuity policyholders who use elderly residential facilities can instruct that their annuity payments be made directly to network service providers, and the company plans to extend this right to savings policyholders soon. Customers also receive special privileges in senior housing, chauffeur services with caregivers, and hospice care hospital services.
3
Asia Plus maintains speculative buy on BCH with target price of 12.00 baht
Asia Plus Securities assesses BCH shares, noting revenue grew 7% YoY in July before accelerating to 10% YoY in August 2026, driven by both Thai and foreign inpatients, supporting hospital revenue growth of 8-9% YoY in the third quarter of 2026. Thai patients were boosted by an early arrival of seasonal diseases; during 13-19 September, new influenza cases rose by 48,100, or 121% from the previous week, and COVID-19 cases reached nearly 35,000, or 119% week-on-week, with 50-60% concentrated in Bangkok. Meanwhile, Middle Eastern patients, especially from Qatar, the UAE, and Saudi Arabia, continued to grow YoY on rising complex disease cases. Myanmar patients are likely to recover after the opening of the new Mae Sai Hospital building in September 2026. Rajavej Ubon Hospital, or KIH Ubon, began recognizing operating results from 1 September 2026, with initial costs from investment of no more than 100 million baht starting in the fourth quarter of 2026. The research team maintains its 2026 net profit forecast at 1.293 billion baht, down 2.7% YoY, and keeps its speculative buy recommendation with a 2027 fair value of 12.00 baht based on DCF, with an adjustment to social security treatment rates as additional upside not yet reflected in estimates.
Ensign Group Slides After Short Seller Reports, Carillon Fund Says
The Ensign Group, Inc. lagged in Carillon Eagle Mid Cap Growth Fund's second-quarter 2026 investor letter after a couple of short-seller reports alleged the company understaffed its skilled nursing facilities to boost profits, violated state staffing rules, falsified care-quality data used in the Centers for Medicare & Medicaid Services' star ratings, and contributed to patient harm. Management pushed back on the claims, noting its facilities are subject to ongoing state and federal audits, including a recent CMS audit of all facilities that produced an error rate significantly better than its competitors'. Carillon said it was not able to substantiate the short-seller claims, and while the stock declined sharply, it has rebounded nicely from its bottom. Ensign closed at $173.91 per share on September 18, 2026, down 3.04% over the past month but up 4.25% over the past 52 weeks, with a market capitalization of $10.14 billion. According to the fund's database, 52 hedge fund portfolios held Ensign at the end of the second quarter, up from 37 in the previous quarter.